Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-311-4 | CAS number: 8002-50-4 Extractives and their physically modified derivatives such as proteins, carbohydrates, lipids, nucleic acids, inorganic ions, etc. obtained from Brevoortia tyrannis.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
Test material
- Reference substance name:
- Algal oil
- IUPAC Name:
- Algal oil
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- ONC T-18 DHA-rich algal oil (lots no. 22630 and 22740; approximately 39–42% docosahexaenoic acid (DHA); total omega-3 fatty acids, approximately 41–44%; storage condition, frozen, -10 to -30 °C) was produced and received from Ocean Nutrition Canada Limited, Dartmouth, Nova Scotia, Canada. Ascorbyl palmitate and mixed natural tocopherols were added to the algal oil to prevent oxidation.
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Female Sprague–Dawley albino rats were obtained from Ace Animals, Inc., Boyertown, PA. The animals were housed individually in stainless steel cages in temperature-controlled and humidity-monitored quarters.
Administration / exposure
- Route of administration:
- other: oral intubation
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 5000 mg/kg of bodyweight
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- The study was conducted in accordance with U.S. Food and Drug Administration (21 CFR Part 58), and the OECD Principles of Good Laboratory Practice ENV/MC/CHEM (98)17). The study design was based on OECD Guideline 425 (OECD, 1997). One female rat was administered a single oral dosage of 5000 mg/kg DHA-rich algal oil/kg of body weight via oral intubation. Due to the absence of mortality in the first rat, two additional female rats received an identical single oral dose of the test article. Each animal was observed for signs of toxicity and behavioural changes for several hours after test article administration and once daily thereafter for 14 days. Mortality/moribundity checks were performed daily. Body weights were recorded before test article administration, at day 7, and at termination. On day 15, rats were killed, necropsies were performed, and any gross observations were recorded.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths occurred during the study.
- Clinical signs:
- None reported.
- Body weight:
- All animals gained body weight during the study.
- Gross pathology:
- No gross abnormalities were noted for any of the animals when necropsied at the conclusion of the 14-day observation period.
- Other findings:
- Apart from diarrhoea and ano-genital staining observed in one rat at 5 h post-dosing, all animals appeared active and healthy over the 14-day observation period. There were no other signs of gross toxicity, adverse pharmacologic effects, or abnormal behaviour.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral LD50 in rats for DHA-rich algal oil has been estimated to be greater than 5000 mg/kg of body weight. Since the GHS criteria for classification are not met, the algal oil is not classified. The composition of menhaden oil is comparable to this oil. Therefore, menhaden oil is also not classified.
- Executive summary:
In this publication by Schmitt et al. 2012 experiments regarding the toxicity of an algal oil are described. Acute oral toxicity was assessed by a guideline study according to OECD Guideline 425. There were no adverse effects observed during the study and LD50 of the test article was greater than 5,000 mg/kg of body weight in female rats. Since the GHS criteria for classification are not met, the algal oil is not classified. The composition of menhaden oil is comparable to this oil. Therefore, menhaden oil is also not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.